SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CIR, CTIC, DFFN


(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

CIRCOR International, Inc. (NYSE: CIR)'s sale to investment funds managed by KKR for $49.00 per share in cash. If you are a CIRCOR shareholder, click here to learn more about your rights and options .

CTI BioPharma Corp. (NASDAQ: CTIC)'s sale to Swedish Orphan Biovitrum AB for $9.10 per share. If you are a CTI BioPharma shareholder, click here to learn more about your rights and options .

Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN)'s merger with EIP Pharma Inc. If you are a Diffusion shareholder, click here to learn more about your rights and options .

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email or .

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060





Tags class action

MENAFN06062023004107003653ID1106396549


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.